Transcription Activator-Like Effector Nuclease (TALEN®)
Showing 1 - 25 of >10,000
Human Papillomavirus-Related Malignant Tumor Trial in Wuhan (T512)
Recruiting
- Human Papillomavirus-Related Malignant Neoplasm
- T512
-
Wuhan, Hubei, ChinaTongji Hospital
Dec 29, 2021
B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)
Recruiting
- B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART20x22
- CLLS52
-
Austin, TexasSarah Cannon - St. David South Austin Medical Center
Dec 8, 2022
B-cell Acute Lymphoblastic Leukemia Trial in France, United States (UCART22)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- UCART22
- CLLS52
-
Los Angeles, California
- +10 more
Sep 23, 2022
Relapsed/Refractory Multiple Myeloma Trial in United States (UCARTCS1A)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- UCARTCS1A
-
San Francisco, California
- +4 more
Nov 11, 2021
Acute Myeloid Leukaemia Trial (UCART123)
Withdrawn
- Acute Myeloid Leukaemia
- UCART123
- (no location specified)
Jul 13, 2020
Peri-Implantitis Trial in Tampere (Lumoral Treatment, Standard treatment for peri-implantitis)
Recruiting
- Peri-Implantitis
- Lumoral Treatment
- Standard treatment for peri-implantitis
-
Tampere, Pirkanmaa, FinlandHammasklinikka Kruunu Oy
May 12, 2023
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
Not yet recruiting
- Pyoderma Gangrenosum
- +2 more
- immunohistochemical methods
- (no location specified)
Mar 21, 2022
MPS I Trial in Oakland (SB-318)
Terminated
- MPS I
- SB-318
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
Jan 6, 2023
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Aug 8, 2022
Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)
Terminated
- Mucopolysaccharidosis II
- MPS II
- SB-913
-
Oakland, California
- +4 more
Oct 21, 2022
Class II Growth Modification Trial in Cairo (Van-Beek activator and a headgear, Andresen activator)
Enrolling by invitation
- Class II Growth Modification
- Van-Beek activator and a headgear
- Andresen activator
-
Cairo, القاهرة, EgyptAlazhar University
Oct 30, 2022
Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)
Recruiting
- Ocular Trauma
- Tissue Plasminogen Activator
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 20, 2023
Lidocaine Bolus and Infusion on Bispectral Index Values and
Recruiting
- Anesthesia Brain Monitoring
- Lidocaine
-
Treviso, TV, ItalyTreviso Regional Hospital
Nov 18, 2023
Midazolam Bolus on Eleveld and Schnider TCI Models
Not yet recruiting
- Propofol
- Anesthesia Brain Monitoring
- (no location specified)
Mar 23, 2023
Effect of Ketamine Infusion on BIS Values
Not yet recruiting
- Anesthesia Brain Monitoring
- Ketamine
- (no location specified)
Apr 3, 2023
Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)
Not yet recruiting
- Hereditary Haemorrhagic Telangiectasia
- Cord blood sampling
- Cord sampling
-
Bron, France
- +2 more
Nov 21, 2022
Immune Aging, Aging Trial in Frankfurt (Softgel containing , Softgel containing 250mg of Urolithin A (Mitopure))
Recruiting
- Immune Aging
- Aging
- Softgel containing placebo
- Softgel containing 250mg of Urolithin A (Mitopure)
-
Frankfurt, GermanyUniversitätsklinikum Frankfurt, Medizinische Klinik I, Gastroent
Feb 9, 2023
Effect of Ketamine on BIS Values
Completed
- Anesthesia Brain Monitoring
- Ketamine
- Bispectral Index
-
Treviso, Tv, ItalyULSS 2 Marca Trevigiana
Nov 24, 2022
HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)
Suspended
- HIV
- Human Immunodeficiency Virus
- Euphorbia kansui extract powder prepared as tea
-
Salt Lake City, UtahUniversity of Utah
Mar 22, 2022
Diaphragm Issues Trial (Stimit Activator 1)
Not yet recruiting
- Diaphragm Issues
- Stimit Activator 1
- (no location specified)
May 20, 2023
Immune Function and the Progression to T1D
Recruiting
- Type 1 Diabetes
- blood draw
-
Gainesville, FloridaKieran McGrail
Jun 12, 2023
Health Subjects Trial (A4368 or tablet)
Completed
- Health Subjects
- A4368 or placebo tablet
-
Seoul, Korea, Republic ofAutophagySciences
Jan 16, 2023
IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Recruiting
- Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
- Non-Interventional
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2023
Solid Tumor Trial in Shanghai (LB4330)
Recruiting
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 31, 2023
Hemophilia B Trial in Washington (SB-FIX)
Terminated
- Hemophilia B
- SB-FIX
-
Washington, District of ColumbiaGeorgetown University Medical Center
Mar 8, 2022